Acquisition

An investor turns an office building into 14 alternative assets, showcasing a complex 1031 exchange strategy driven by state housing mandates and market shifts.

With a new CEO and President set to take over in 2026, Oakbridge Insurance is doubling down on its growth-by-acquisition and producer-centric model.

Genomics leader IDT launches its first IVD-grade NGS tests for cancer, aiming to standardize diagnostics and accelerate precision medicine.

The L.A.-based bank extends its $300M stock repurchase program and will redeem $385M in notes, a move analysts see as a confident financial play.

Private equity firm OEP takes UK food distributor Kitwave private, signaling a major M&A push in Britain's fragmented wholesale supply chain.

Pharma giant Sanofi inks a massive deal for Kali Therapeutics' KT501, a novel T-cell engager aiming to reset the immune system in autoimmune diseases.

T1 Energy's upcoming results are the first major test of its pivot to U.S. solar manufacturing. Can it deliver on its high-stakes bet?

With a promising non-opioid drug and new leadership known for major deals, Persica Pharmaceuticals is poised to revolutionize back pain treatment.

An $80 million settlement aims to close the chapter on The Villages Health bankruptcy, a crisis sparked by hundreds of millions in Medicare billing errors.

With a 1,000-home goal and a founder who built an $825M company, this startup says its data-driven model can quadruple revenue for property owners.

The Reston firm joins an elite group on the GSA's massive Alliant 3 vehicle, unlocking major federal IT projects and signaling a new era for procurement.

As Capital One preps its Q1 2026 results, all eyes are on whether its pioneering tech strategy can navigate economic headwinds and justify its big bets.

Fintech giant Bilt is expanding beyond rent into dining with a new tech platform, aiming to connect your home, meals, and entire neighborhood.

An ambitious redevelopment at Tower 49, led by Kato International and Industrious, is creating a new blueprint for the future of work in Manhattan.

Dave Cantin Group's strategic hire of Nate Klebacha signals a new era of data-driven M&A as dealership consolidation continues to accelerate.

NEO Home Loans adopts Better's AI to slash mortgage decision times, signaling a new era of speed. But what are the risks behind the efficiency?

Richtech Robotics hires top-tier auditor CBIZ, citing a strategic shift, but SEC filings reveal a prior warning about a “material weakness” in controls.

Apple iSports hires innovation guru Ian Wilding to guide its Nasdaq ambitions, a move underscored by a corrective press release signaling growing pains.

With a history of billion-dollar deals, Mark Altmeyer takes the helm at ReproNovo, aiming to commercialize its promising fertility and women's health pipeline.

China Natural Resources, with a tiny $5M market cap, plans to buy a majority stake in AI startup HooRii for $40M, a high-risk pivot for survival.